CD79A and Immunodeficiency: Immunodeficiency is another pronounced feature in two thirds of AT patients, which is demonstrated by a lack of antibody response to vaccines, reduced B and T cell numbers, and decreased production of at least one immunoglobulin subclass (IgG, IgA, and IgM) (104–106).